were from Bloomington stock center. UAS ex RNAi, UAS mer RNAi, UAS kibra RNAi (on the X) are from the VDRC stock center. kibra mutant and transgenics w; FRT82B kibra
32
Quantification of inter-ommatidial cell number 40-hour-APF retinas were stained with an anti-Arm antibody to label the cell outlines. The IOCs for a single ommatidium were quantified by drawing a hexagon connecting the centres of the six surrounding neighbouring ommatidia. All IOCs within that hexagon were then counted. Cells straddling the boundary of the hexagon were counted as half a cell. For each genotype, 46 nonoverlapping hexagons from the retinas of 5 different animals were counted.
RNAi production dsRNAs were synthesized with a Megascript T7 kit (Ambion). DNA templates for dsRNA synthesis were PCR-amplified from plasmids using primers that contained the 5' T7 RNA polymerase-binding site sequence. The following primers were used:
-5'-GAGTTCTGCACCGAGGAGAC, -3'-TCATCCTTAGCCGTCAGCTT.
Plasmids
Expression plasmids were generated using the Gateway technology (Invitrogen). Open reading frames (ORF) were PCR-amplified from cDNA (DGRC, https://dgrc.cgb.indiana.edu/vectors/) and cloned into Entry vectors (pDONR207, pDONR/Zeo, pENTR-D-TOPO). For Destination vectors, the pAMW, pAWH and pAWF plasmids from the Drosophila Gateway Vector Collection (http://www.ciwemb.edu/labs/murphy/Gateway%20vectors.html) were used, as well as the pUASP plasmid (for transgenics). The expanded and merlin ORFs were gifts from G. Halder, the warts ORF was a gift from D. Pan. All Entry vectors were sequence-verified. The point mutations were generated using the Quickchange Multi Site-Directed Mutagenesis Kit (Stratagene). For Ex-P845A, a CCG was mutated to a GCG. For Kibra-P85A, a CCC was mutated to a GCC and for Kibra-P132A, a CCG to a GCG.
Co-immunoprecipitation of proteins
Co-IP after transfection. S2R+ cells, grown in Shields and Sang M3 insect medium (Sigma) supplemented with 10% FCS and 1% Penicillin/Streptomycin, were transfected with the indicated plasmids using Effectene according to the manufacturer's instructions. The cells were allowed to express the plasmids for 72 hrs, washed once in PBS and lysed in lysis buffer (50 mM Tris pH 7.5, 150 mM NaCl, 1% NP40, 1 mM EGTA, "Complete" protease inhibitor tablet (Roche), Phosphatase Inhbitor II (Sigma), 20 mM NaF). 300 µg lysate per sample was incubated with either anti-Myc (1:300, anti-rabbit, Santa Cruz) or anti-HA (1:300, anti-rabbit, Abcam) antibodies for 1 hour at 4C, and then incubated with Protein-A sepharose beads for 1 hour at 4C. The beads were washed 3x, and the bound proteins were denatured using NuPAGE reducing and NuPAGE loading buffer (Invitrogen). IP samples and 10% input (30 µg lysate) were run on NuPAGE Protein gels (Invitrogen) and Western blots were probed with anti-Myc (1:1000, anti-mouse, Santa Cruz) and anti-HA (1:1000, anti-rat, Roche) antibodies.
Endogenous co-IPs. S2 cells were cultured in 15 cm Petri dishes in Schneider's medium (Invitrogen) supplemented with 10% FCS and 1% Penicillin/Streptomycin. Cells were treated with 250 µg of RNAi for 4 days, and lysed in 2 mL of the lysis buffer described above. 5 mg lysate per sample was incubated with either anti-Yki (10 µL per IP, anti-rat, generated by Eurogentec SA against the last 15 amino acids of the protein) or with the pre-immune serum from this anti-Yki (5 µL per IP) for 1,5 hour at 4C, and then incubated with Protein-G sepharose beads for 1,5 hour at 4C. The beads were washed 4x, and the bound proteins were denatured using NuPAGE reducing and NuPAGE loading buffer (Invitrogen). Western blot as above, except with 1% input (50 µg lysate). Samples were probed with preblocked rabbit antiWts (1/10 000, gift from K. Irvine), rat anti-Yki or rabbit anti-Yki (1/2000, gift from D. Pan), rabbit anti-Kibra (see Immunostainings) and rabbit anti P-Yki (1/1000, made by Eurogentec SA against peptide HHSRAR(pS)SPA).
Quantitative RT-PCR MS1096>> (control) and MS1096>>yki wing discs were dissected in PBS and snap-frozen in liquid nitrogen. RNA isolation and subsequent qRT-PCR reactions were performed as described in (Genevet et al., 2009 ). All reactions were performed in four replicates. The relative amount of specific mRNAs under each condition was calculated after normalization to the histone 3 (his3) transcript. For his3 mRNA : -5'-GTGAAGTAGTGAACGTGAAC, -3'-CCGCCGAGCTCTGGAATCGC. For ex mRNA :
-5'-CAGCAGCAGCCGAAAACCT, -3'-GGCGGGACGTCTCATCTTTC. For kibra mRNA :
-5'-CAGCATCTATCGACGCGGTG, -3'-CCGCTCATCGCTTCGTAGGG
Split-TEV luciferase assays
For split-TEV experiments, human KIBRA was recombined into a pcDNA3-DEST_Cter-NTEV-tevS-GV vector. Also, human KIBRA, FRMD6, NF2 variant2, MST2 and RASSF6 were cloned into a pTag4C-DEST_Cter-CTEV vector. The GCN4cc-N/CTEV and human FKBP-CTEV constructs were previously described (Wehr et al., 2006) . HEK293 cells were cultured in DMEM/GlutaMAX TM low glucose (Invitrogen) supplemented with 10% FCS and 1% Penicillin/Streptomycin. Luciferase reporter assays were performed a 96-well format with 6 wells per condition, and 20 ng of DNA per plasmid per well was used. Indicated combinations of plasmids plus the UASFirefly luciferase (pFR-Luc, Stratagene) were transfected into HEK293 cells using LipofectamineLTX according to the manufacturer's instructions. 1 ng of a mix of Renilla Luciferases, driven by SV40, TK and CMV promoters at a molar ratio of 10:2:1, was cotransfected as internal control. After transfection, plasmids were allowed to express 24h, and the cells were lysed in Passive Lysis buffer (Promega). Coupled Firefly and Renilla luciferase assays were run in a BMG PHERAstar reader (IMGEN Technologies) using the Dual Luciferase Kit (Promega). Figure 1A : w; hh>Gal4 /+ (3rd) Figure 1B : UAS kibra RNAi / w; hh>Gal4 /+ Figure 1C : UAS wts RNAi / hh>Gal4 Figure 1D ,G: ey>Gal4 GMR>Gal4 /+ (2nd) Figure 1E ,H: UAS kibra RNAi / w; ey>Gal4 GMR>Gal4 /+ Figure 1F ,I: ey>Gal4 GMR>Gal4 /+ ; UAS wts RNAi /+ Figure 1K ,M,T: yw eyFLP/ w;; FRT82B GFP/ FRT82B Figure 1L Figure S3L : GMR>Gal4 /UAS kibra RNAi Figure S3M : GMR>Gal4 /+; UAS ex RNAi/+ Figure S3N : GMR>Gal4 /UAS kibra RNAi; UAS mer RNAi/+
Genotypes

